The Transendocardial Autologous Cells (hMSC or hBMC) in Ischemic Heart Failure Trial (TAC-HFT)

NCT00768066 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

65

Enrollment

OTHER

Sponsor class

Conditions

Stem Cell Transplantation
Ventricular Dysfunction, Left

Interventions

BIOLOGICAL: Autologous human mesenchymal cells (hMSCs)
BIOLOGICAL: Autologous human bone marrow cells (hBMCs)
BIOLOGICAL: Placebo

Sponsor

University of Miami

Collaborators

[object Object]